Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958966 · ClinicalTrials.gov registry record · NA
Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT05958966 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 73 participants.
The verdict
NCT05958966, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect product appeal across young adult e-cigarette users and middle-age/older adult smokers; (2) Determine which dimensions of e-cigarette product diversity differentially affect product appeal in the overall population of tobacco product users as well as affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile. For this substudy, adult smokers (N=200) will attend two laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, nicotine formulation) and smoke their own cigarettes.
Interventions
- OTHER E-cigarette e-liquid self-administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05958966
The ClinicalTrials.gov registry entry for NCT05958966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which E-cigarette e-liquid self-administration is the first listed.
NCT05958966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05958966 about?
NCT05958966 is a clinical study titled "Effects of e-Cigarettes on Perceptions and Behavior - Substudy 2". This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes. Ther...
What is the current status of trial NCT05958966?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2022-04-01. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05958966?
The interventions under investigation include: E-cigarette e-liquid self-administration (OTHER).
Who is sponsoring clinical trial NCT05958966?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.